Product Information

ISOTRETINOIN 30 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $5.6970 per EA under NDC 59651063403. Its NADAC has been published 108 times since Oct 30, 2024.

FDA first approved this application on Jan 29, 2024. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ISOTRETINOIN 30 MG CAPSULE

ISOTRETINOIN
$5.6970per EA

Strength

30 mg/1

NDC

59651063403

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ISOTRETINOIN

Approval Type

Generic (ANDA)

FDA Application

ANDA218194

FDA Approved

1/29/2024

TE Code

AB2

On Market Since

1/29/2024

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ISOTRETINOIN 30 MG CAPSULE has been published 108 times since Oct 30, 2024, and over the history we have for it it has declined 62.8%. The table below summarizes its recorded NADAC range and movement.

Current price$5.6970 per EA
All-time high$15.6500 (Dec 11, 2024)
All-time low$3.6838 (Aug 19, 2026)
52-week high$8.8687
52-week low$3.6838
Median price$9.8880
Average price$8.8919
Largest weekly change+21.4% (Sep 23, 2026)
Weeks tracked108
Tracking sinceOct 30, 2024

Price History

1W

+5.0%

1M

+27.4%

3M

+54.7%

6M

+27.2%

1Y

-35.8%

3Y

N/A

5Y

N/A

All

-62.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ISOTRETINOIN 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ISOTRETINOIN 30 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $5.6970 per EA (NDC 59651063403), effective Nov 18, 2026.

How has the price of ISOTRETINOIN 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ISOTRETINOIN 30 MG CAPSULE has declined 62.8%. It has been tracked across 108 weekly CMS publications since Oct 30, 2024.

What are the highest and lowest recorded NADAC prices for ISOTRETINOIN 30 MG CAPSULE?

Since Oct 30, 2024, the NADAC for ISOTRETINOIN 30 MG CAPSULE has ranged from a low of $3.6838 (Aug 19, 2026) to a high of $15.6500 (Dec 11, 2024), with a median of $9.8880 per EA.

Are there cheaper alternatives to ISOTRETINOIN 30 MG CAPSULE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZENATANE 30 MG CAPSULE, is $1.9816 per EA — about 65% below ISOTRETINOIN 30 MG CAPSULE.

Who manufactures ISOTRETINOIN 30 MG CAPSULE?

ISOTRETINOIN 30 MG CAPSULE (NDC 59651063403) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.